Global Women's Health Diagnostics Market Size, Share & Trends Analysis Report 2018: Epidemiological Shift from Infectious Diseases to Chronic Diseases

DUBLIN, Oct. 30, 2018 /PRNewswire/ --

The "Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End Use, By Application (Cancer, Infectious Disease, Osteoporosis, Pregnancy, Prenatal), and Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global women's health diagnostics market size is expected to reach USD 76.2 billion by 2025

Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Further key findings from the report suggest:

• Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
• Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
• Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
• Geographically, North America was the leading revenue contributor to the women's health diagnostics market in 2017. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices
• Some of the key players are Siemens Healthcare Private Limited; Hologic, Inc.;GE Healthcare; F. Hoffmann-La Roche Ltd.; bioMrieux SA; Koninklijke Philips N.V; Abbott; Becton, Dickinson and Company, Quest Diagnostics, Inc.; and PerkinElmer, Inc.

Key Topics Covered:

Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Incidence of various chronic and lifestyle disorders in women
3.1.1.2 Increasing adoption of point-of-care diagnostics
3.1.1.3 Increasing number of diagnostic and imaging centers
3.1.1.4 High prevalence of infectious diseases among women
3.1.2 Market restraint analysis
3.1.2.1 Lack of skilled laboratory technicians
3.1.2.2 High cost
3.2 Penetration & Growth Prospects Mapping
3.3 Women's Health Diagnostics Market - PESTLE Analysis
3.4 Industry Analysis - Porter's
3.5 Women's Health Diagnostics Competitive Landscape: Market Position Analysis (Based on Services, Regional Presence, and Recent Updates)

Chapter 4 Women's Health Diagnostics Market : Application Estimates & Trend Analysis
4.1 Women's Health Diagnostics Market: Application Analysis
4.2 Cancer Testing
4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.2.1.1 Breast cancer
4.2.1.2 Cervical cancer
4.2.1.3 Ovarian cancer
4.3 Infectious Disease Testing
4.4 Osteoporosis Testing
4.5 Pregnancy and Fertility Testing
4.6 Prenatal Testing

Chapter 5 Women's Health Diagnostics Market : End Use Estimates & Trend Analysis
5.1 Women's Health Diagnostics Market: End Use Analysis
5.2 Hospital and Diagnostics Centers
5.3 Home

Chapter 6 Women's Health Diagnostics Market : Regional Estimates & Trend Analysis

Chapter 7 Competitive Landscape

• Siemens Healthcare GmBH
• Hologic, Inc.
• GE Healthcare
• F. Hoffmann-La Roche Ltd
• bioMrieux SA
• Koninklijke Philips N.V.
• Abbott
• Becton, Dickinson and Company
• Quest Diagnostics, Inc.
• PerkinElmer, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/vkbwql/global_womens?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com